The relation between oxidant and antioxidant parameters and severity of acute coronary syndromes

References

• Holschermann H, Tillmanns H, Bode C. Pathophysiology of acute coronary syndrome. Hamostaseologie 2006; 26: 99–103.
   Google Scholar
• Fox KAA. Management of acute coronary syndromes: an update. Heart 2004; 90: 698–706.
   Google Scholar
• Elahi MM, Matata BM. Free radicals in blood: evolving concepts in the mechanism of ischemic heart disease. Arch Biochem Biophys 2006; 450: 78–88.
   Google Scholar
• Halliwell B, Gutteridge JM, Cross CE. Free radicals, antiox-idants, and human disease: where are we now? J Lab Clin Med 1992; 119: 598–620.
   Google Scholar
• Fuster V, Badimon L, Badimon JJ, Chesebro JH. The patho-genesis of coronary artery disease and the acute coronary syndromes. N Engl J Med 1992; 326: 310–8.
   Google Scholar
• Steinberg D, Witztum JL. Lipoproteins and atherogenesis. JAMA 1990; 264: 3047–52.
   Google Scholar
• Stadtman ER, Levine RL. Protein oxidation. Ann N Y AcadSci 2000; 899: 191–208.
   Google Scholar
• Ehara S, Ueda M, Naruko T, Haze K, Itoh A, Otsuka M, Komatsu R, Matsuo T, Itabe H, Takano T, Tsukamoto Y, Yoshiyama M, Takeuchi K, Yoshikawa J, Becker AE. Ele-vated levels of oxidized low density lipoprotein show a pos-itive relationship with the severity of acute coronary syn-dromes. Circulation 2001; 103: 1955–60.
   Google Scholar
• Skvarilova M, Bulava A, Stejskal D, Adamovs.ka S, Bartek J. Increased level of advanced oxidation products (AOPP) as a marker of oxidative stress in patients with acute coronary syndrome. Biomed Pap 2005; 149: 83–7.
   Google Scholar
• Lindberg G, Rastam L, Gullberg B, Lundblad A, Nilsson-Ehle P, Hanson BS. Serum concentrations of total sialic acid and sialoglycoproteins in relation to coronary heart disease risk markers. Atherosclerosis 1993; 103: 123–9.
   Google Scholar
• Crook M, Haq M, Haq S, Tutt P. Plasma sialic acid and acute-phase proteins in patients with myocardial infarction. Angiology 1994; 45: 709–15.
   Google Scholar
• Berkan 0, Sagban M. Sialic acid or troponin T to detect pen-operative myocardial damage in patients undergoing elective coronary artery bypass grafting. Circ J2002; 66: 1019-23.
   Google Scholar
• Gokmen SS, Kilici G, Ozcelik F, Gulen S. Serum total and lipid-bound sialic acid levels following acute myocardial infarction. Clin Chem Lab Med 2000; 38: 1249–55.
   Google Scholar
• Allain P, Olivier E, Le Bouil A, Benoit C, Geslin P, Tadei A. Increase of sialic acid concentration in the plasma of patients with coronary disease. Presse Med 1996; 25: 96–8.
   Google Scholar
• Libby P. Current concepts of the pathogenesis of the acute coronary syndromes. Circulation 2001; 104: 365–72.
   Google Scholar
• Devasagayam TP, Tilak JC, Boloor KK, Sane KS, Ghaskadbi SS, Lele RD. Free radicals and antioxidants in human health: current status and future prospects. J Assoc Physicians India 2004; 52: 794–804.
   Google Scholar
• Durrington PN, Mackness B, Mackness MI. Paraoxonase and atherosclerosis. Arterioscler Tromb Vasc Biol 2001; 21:473–80.
   Google Scholar
• Gan KN, Smolen A, Eckerson H.W, La Du BN. Purification of human serum paraoxonase/arylesterase: Evidence for one esterase catalyzing both activities. Drug Metab Dispos 1991; 19: 100–6.
   Google Scholar
• Aviram M, Rosenblat M, Bisgaier CL. Paraoxonase inhibits high-density lipoprotein oxidation and preserves its func-tions. A possible peroxidative role for paraoxonase. J Clin Invest 1998; 101: 1581–90.
   Google Scholar
• Ng CJ, Shih DM, Hama SY, Villa N, Navab M, Reddy ST. The paraoxonase gene family and atherosclerosis. Free Radic Biol Med 2005; 38: 153–63.
   Google Scholar
• Senthil S, Veerappan RM, Ramakrishna Rao M, Pugalendi KV. Oxidative stress and antioxidants in patients with car-diogenic shock complicating acute myocardial infarction. Clin Chim Acta 2004; 348: 131–7.
   Google Scholar
• Ayub A, Mackness MI, Arrol S, Mackness B, Patel J, Dur-rington PN. Serum paraoxonase after myocardial infarction. Arterioscler Thromb Vasc Biol 1999; 19: 330–5.
   Google Scholar
• Yesilbursa D, Serdar Z, Dirican M, Serdar A, Gullulu S, Cordan J. Susceptibility of apolipoprotein B-containing lipoproteins to oxidation and antioxidant status in acute coronary syndromes. Clin Cardiol 2000; 23: 655–8.
   Google Scholar
• Kabaroglu C, Mutaf I, Boydak B, Ozmen D, Habif S, Erdener D, Parildar Z, Bayindir 0. Association between serum paraoxonase activity and oxidative stress in acute coronary syndromes. Acta Cardiol 2004; 59: 606–11.
   Google Scholar
• Greenland P, Smith SC, Grundy SM. Improving coronary heart disease assessment in asymptomatic people. Role of traditional risk factors and noninvasive cardiovascular tests. Circulation 2001; 104: 1863–7.
   Google Scholar
• Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of preparative ultracentrifuge. Clin Chem 1972; 18: 499–502.
   Google Scholar
• Sydow G. A simplified quick method for determination of sialic acid in serum. Biomed Biochem Acta 1985; 44: 1721.
   Google Scholar
• Young IS, Trimble ER. Measurement of malondialdehyde in plasma by high performance liquid chromatography with fluorimetric detection. Ann Clin Biochem 1991; 28: 504–8.
   Google Scholar
• Reznick AZ, Packer L. Oxidative damage to proteins: spec-trophotometric method for carbonyl assay. Methods Enzy-mol 1994; 233: 357–63.
   Google Scholar
• Eckerson HW, Wyte MC, La Du BN. The human serum paraoxonase/arylesterase polymorphism. Am J Hum Genet 1983; 35: 1126–38.
   Google Scholar
• Haagen L, Brock A. A new automated method for pheno-typing arylesterase (E.C.3.1.1.2.) based upon inhibition of enzymatic hydrolysis of 4-nitrophenyl acetate by phenyl acetate. Eur J Clin Chem Clin Biochem 1992; 30: 391–5.
   Google Scholar
• Teissier E, Walters-Laporte E, Duhem C, Luc G, Fruchart JC, Duriez P. Rapid quantification of a-tocopherol in plasma and low- and high-density lipoproteins. Clin Chem 1996: 42: 430–5.
   Google Scholar
• McCormick DB, Greene HL. Vitamins. In: Burtis CA, Ash-wood ER, eds. Tietz Textbook of Clinical Chemistry. W.B. Saunders Co, Philadelphia, 1994: 313-4.
   Google Scholar
• Neeld JB, Pearson WN. Macro-and micromethods for deter-mination of serum vitamin A using trifluoroacetic acid. J Nutr 1963; 79: 454–62.
   Google Scholar
• Stocker R, Keaney JF. Role of oxidative modifications in atherosclerosis. Physiol Rev 2004; 84: 1381–478.
   Google Scholar
• Nand N, Budhiraja N, Singh GP, Sharma M, Aggarwal HK. Lipid peroxidation and vitamin E in ischemic heart disease. J Assoc Physicians India 1997; 45: 839–42.
   Google Scholar
• Fainaru 0, Fainaru M, Assali AR, Pinchuk I, Lichtenberg D. Acute myocardial infarction is associated with increased susceptibility of serum lipids to copper-induced peroxida-tion in vitro. Clin Cardiol 2002; 25: 63–8.
   Google Scholar
• Cikim G, Canatan H, Gursu MF, Gulcu F, Baydas G, Kil-icoglu AE. Levels of zinc and lipid peroxidation in acute coronary syndrome. Biol Trace Elem Res 2003; 96: 61–9.
   Google Scholar
• Chevion M, Berenshtein E, Stadtman ER. Human studies related to protein oxidation: Protein carbonyl content as a marker of damage. Free Rad Res 2000; 33: 99–108.
   Google Scholar
• Kaneda H, Taguchi J, Ogasawara K, Aizawa T, Ohno M. Increased level of advanced oxidation protein products in patients with coronary artery disease. Atherosclerosis 2002; 162: 221–5.
   Google Scholar
• Tatarkova Z, Kaplan P, Matejovicova M, Lehotsky J, Dobrota D, Flameng W Effect of ischemia and reperfusion on protein oxidation in isolated rabbit hearts. Physiol Res 2005; 54: 185–91.
   Google Scholar
• Sonmez H, Suer S, Ulutin T, Kokoglu E, Ucisik N. The relationship of various factors in the pathogenesis of atherosclerosis. Clin Appl Thrombosisl Hemostasis 1998; 4: 105–10.
   Google Scholar
• Gokmen SS, Kazezoglu C, Sunar B, Ozcelik F, Gungor 0, Yorulmaz F, Gulen S. Relationship between serum sialic acids, sialic acid-rich inflammation-sensitive proteins and cell damage in patients with acute myocardial infarction. Clin Chem Lab Med 2006; 44: 199–206.
   Google Scholar
• Herbaczynska-Cedro K, Kosiewicz-Wasek B, Cedro K, Wasek W, Panczenko-Kresowska B, Wartanowicz M. Sup-plementation with vitamins C and E suppresses leukocyte oxygen free radical production in patients with myocardial infarction. Eur Heart J1995; 16: 1044-9.
   Google Scholar
• Singh RB, Niaz MA, Sharma JP, Kumar R, Bishnoi I, Begom R. Plasma levels of antioxidant vitamins and oxida-tive stress in patients with acute myocardial infarction. Acta Cardiol 1994; 49: 441–52.
   Google Scholar
• Gasparetto C, Malinvemo A, Culacciati D, Gritti D, Pros-perini PG, Specchia G, Ricevuti G. Antioxidant vitamins reduce oxidative stress and ventricular remodeling in patients with acute myocardial infarction. Int J Immunopathol Phar-macol 2005; 18: 487–96.
   Google Scholar
• Getz GS, Reardon CA. Paraoxonase, a cardioprotective enzyme: continuing issues. Curr Opin Lipidol 2004; 15:261–7.
   Google Scholar
• Azarsiz E, Kayikcioglu M, Payzin S, Sozmen EY. PON1 activities and oxidative markers of LDL in patients with angiographically proven coronary artery disease. Int J Car-diol 2003; 91: 43–51.
   Google Scholar